Eosinophilic esophagitis-linked calpain 14 is an IL-13-induced protease that mediates esophageal epithelial barrier impairment

JCI Insight

Volumn 1, Issue 4, 2016, Pages

  Davis, Benjamin P ^a   Stucke, Emily M ^a   Khorki, M Eyad ^a   Litosh, Vladislav A ^a   Rymer, Jeffrey K ^a   Rochman, Mark ^a   Travers, Jared ^a   Kottyan, Leah C ^a   Rothenberg, Marc E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84990832667     PISSN: None     EISSN: 23793708     Source Type: Journal    
DOI: 10.1172/jci.insight.86355     Document Type: Article

References (33)

1. Kottyan LC, et al. Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet. 2014; 46(8):895-900.
2. Sleiman PM, et al. GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun. 2014; 5:5593.
3. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003; 83(3):731-801.
4. Ono Y, Sorimachi H. Calpains: an elaborate proteolytic system. Biochim Biophys Acta. 2012; 1824(1):224-236.
5. Sorimachi H, Hata H, Ono O. Calpain chronicle - an enzyme family under multidisciplinary characterization. Proc Jpn Acad Ser B Phys Biol Sci. 2011; 87(6):287-327.
6. Chakraborti S, Alam MN, Paik D, Shaikh S, Chakraborti T. Implications of calpains in health and diseases. Indian J Biochem Biophys. 2012; 49(5):316-328.
7. Ueta M, Sotozono C, Kinoshita S. Expression of interleukin-4 receptor α in human corneal epithelial cells. Jpn J Ophthalmol. 2011; 55(4):405-410.
8. Sherrill JD, et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol. 2014; 7(3):718-729.
9. Blanchard C, et al. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol. 2007; 120(6):1292-1300.
10. Calpain-Glo Protease Assay Technical Bulletin. Promega Web site. https://www.promega.com/resources/protocols/technical-bulletins/101/calpain-glo-protease-assay-protocol/. Updated December 1, 2015. Accessed March 16, 2016.
11. Hsu CY, et al. Deimination of human filaggrin-2 promotes its proteolysis by calpain 1. J Biol Chem. 2011; 286(26):23222-23233.
12. Yamazaki M, et al. Cytoplasmic processing of human profilaggrin by active mu-calpain. Biochem Biophys Res Commun. 1997; 235(3):652-656.
13. Palmer CN, et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006; 38(4):441-446.
14. Wills-Karp M, et al. Interleukin-13: central mediator of allergic asthma. Science. 1998; 282(5397):2258-2261.
15. Lampe WR, Park J, Fang S, Crews AL, Adler KB. Calpain and MARCKS protein regulation of airway mucin secretion. Pulm Pharmacol Ther. 2012; 25(6):427-431.
16. Konze SA, et al. Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells. Mol Cell Proteomics. 2014; 13(4):990-1007.
17. Samuelov L, et al. Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet. 2013; 45(10):1244-1248.
18. Ono Y, et al. Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J Biol Chem. 1998; 273(27):17073-17078.
19. Krahn M, et al. CAPN3 mutations in patients with idiopathic eosinophilic myositis. Ann Neurol. 2006; 59(6):905-911.
20. Taveau M, Bourg N, Sillon G, Roudaut C, Bartoli M, Richard I. Calpain 3 is activated through autolysis within the active site and lyses sarcomeric and sarcolemmal components. Mol Cell Biol. 2003; 23(24):9127-9135.
21. Rajakumar D, Alexander M, Oommen A. Oxidative stress, NF-κB and the ubiquitin proteasomal pathway in the pathology of calpainopathy. Neurochem Res. 2013; 38(10):2009-2018.
22. Liu L, Xing D, Chen WR, Chen T, Pei Y, Gao X. Calpain-mediated pathway dominates cisplatin-induced apoptosis in human lung adenocarcinoma cells as determined by real-time single cell analysis. Int J Cancer. 2008; 122(10):2210-2222.
23. Elias PM, et al. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am J Pathol. 2008; 173(3):689-699.
24. Karlsson I, et al. Solenopsin A and analogs exhibit ceramide-like biological activity. Vasc Cell. 2015; 7:5.
25. Lin MS, et al. Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest. 2000; 105(2):207-213.
26. Hayakawa M, Hayakawa H, Matsuyama Y, Tamemoto H, Okazaki H, Tominaga S. Mature interleukin-33 is produced by calpain-mediated cleavage in vivo. Biochem Biophys Res Commun. 2009; 387(1):218-222.
27. Zuo L, et al. IL-13 induces esophageal remodeling and gene expression by an eosinophil-independent, IL-13Rα 2-inhibited pathway. J Immunol. 2010; 185(1):660-669.
28. Lu TX, et al. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol. 2012; 129(4):1064-1075.
29. Langmead B, Trapnell C, Pop M, Salzberg SL. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25.
30. Trapnell C, Hendrickson DG, Sauvageau M, Goff L, Rinn JL, Pachter L. Differential analysis of gene regulation at transcript resolution with RNA-seq. Nat Biotechnol. 2013; 31(1):46-53.
31. Garber M, Grabherr MG, Guttman M, Trapnell C. Computational methods for transcriptome annotation and quantification using RNA-seq. Nat Methods. 2011; 8(6):469-477.
32. Harada H, et al. Telomerase induces immortalization of human esophageal keratinocytes without p16INK4a inactivation. Mol Cancer Res. 2003; 1(10):729-738.
33. Jovov B, Que J, Tobey NA, Djukic Z, Hogan BL, Orlando RC. Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol. 2011; 106(6):1039-1047.